{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:51:35Z","timestamp":1670309495704},"reference-count":46,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-16-0198","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T22:39:51Z","timestamp":1464647991000},"page":"1556-1563","source":"Crossref","is-referenced-by-count":4,"title":["Impacts of Surgically Performed Renal Denervation on the Cardiovascular and Electrophysiological Variables in the Chronic Atrioventricular Block Dogs\u3000\u2013 Comparison With Those of Amiodarone Treatment \u2013"],"prefix":"10.1253","volume":"80","author":[{"given":"Takeshi","family":"Wada","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"},{"name":"Department of Cardiology, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ohara","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Murakoshi","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sato","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Aonuma","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nakazato","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Juntendo University School of Medicine, Urayasu Hospital Heart Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Esler M, Jennings G, Korner P, Blombery P, Burke F, Willett I, et al. Total, and organ-specific, noradrenaline plasma kinetics in essential hypertension. <i>Clin Exp Hypertens A<\/i> 1984; 6: 507\u2013521.","DOI":"10.3109\/10641968409062580"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. <i>. Hypertension<\/i> 1988; 11: 3\u201320.","DOI":"10.1161\/01.HYP.11.1.3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. <i>J Am Coll Cardiol<\/i> 2009; 54: 1747\u20131762.","DOI":"10.1016\/j.jacc.2009.05.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, et al. Sympathetic nerve activity in end-stage renal disease. <i>Circulation<\/i> 2002; 106: 1974\u20131979.","DOI":"10.1161\/01.CIR.0000034043.16664.96"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. B\u00f6hm M, Linz D, Urban D, Mahfoud F, Ukena C. Renal sympathetic denervation: Applications in hypertension and beyond. <i>Nat Rev Cardiol<\/i> 2013; 10: 465\u2013476.","DOI":"10.1038\/nrcardio.2013.89"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, B\u00f6hm M, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. <i>Lancet<\/i> 2010; 376: 1903\u20131909.","DOI":"10.1016\/S0140-6736(10)62039-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months. <i>Hypertension<\/i> 2011; 57: 911\u2013917.","DOI":"10.1161\/HYPERTENSIONAHA.110.163014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ukena C, Mahfoud F, Spies A, Kindermann I, Linz D, Cremers B, et al. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. <i>Int J Cardiol<\/i> 2013; 167: 2846\u20132851.","DOI":"10.1016\/j.ijcard.2012.07.027"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bhatt DL, Kandzari DE, O\u2019Neill WW, D\u2019Agostino R, Flack JM, Katzen BT, et al; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. <i>N Engl J Med<\/i> 2014; 370: 1393\u20131401.","DOI":"10.1056\/NEJMoa1402670"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kario K, Ogawa H, Okumura K, Okura T, Saito S, Ueno T, et al. SYMPLICITY HTN-Japan: First randomized controlled trial of catheter based renal denervation in Asian patients. <i>Circ J<\/i> 2015; 79: 1222\u20131229.","DOI":"10.1253\/circj.CJ-15-0150"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Linz D, Wirth K, Ukena C, Mahfoud F, P\u00f6ss J, Linz B, et al. Renal denervation suppress ventricular arrhythmias during acute ventricular ischemia in pigs. <i>Heart Rhythm<\/i> 2013; 10: 1525\u20131530.","DOI":"10.1016\/j.hrthm.2013.07.015"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, et al. Renal sympathetic denervation for treatment of electrical storm: First-in-man experience. <i>Clin Res Cardiol<\/i> 2012; 101: 63\u201367.","DOI":"10.1007\/s00392-011-0365-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. <i>J Am Coll Cardiol<\/i> 2012; 60: 1163\u20131170.","DOI":"10.1016\/j.jacc.2012.05.036"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sugiyama A, Ishida Y, Satoh Y, Aoki S, Hori M, Akie Y, et al. Electrophysiological, anatomical and histological remodeling of the heart to AV block enhances susceptibility to arrhythmogenic effects of QT-prolonging drugs. <i>Jpn J Pharmacol<\/i> 2002; 88: 341\u2013350.","DOI":"10.1254\/jjp.88.341"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Vos MA, de Groot SH, Verduyn SC, van der Zande J, Leunissen HD, Cleutjens JP, et al. Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. <i>Circulation<\/i> 1998; 98: 1125\u20131135.","DOI":"10.1161\/01.CIR.98.11.1125"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wang K, Takahara A, Nakamura Y, Aonuma K, Matsumoto M, Sugiyama A. In vivo electropharmacological effects of amiodarone and candesartan on atria of chronic atrioventricular block dogs. <i>J Pharmacol Sci<\/i> 2007; 103: 207\u2013213.","DOI":"10.1254\/jphs.FP0060945"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Volders PGA, Sipido KR, Vos MA, Kulcsar A, Verduyn SC, Wellens HJ. Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsade de pointes. <i>Circulation<\/i> 1998; 98: 1136\u20131147.","DOI":"10.1161\/01.CIR.98.11.1136"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. <i>Circulation<\/i> 1999; 100: 87\u201395.","DOI":"10.1161\/01.CIR.100.1.87"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Iwasaki H, Takahara A, Nakamura Y, Satoh Y, Nagai T, Shinkai N, et al. Simultaneous assessment of pharmacokinetics of pilsicainide transdermal patch and its electropharmacological effects on atria of chronic atrioventricular block dogs. <i>J Pharmacol Sci<\/i> 2009; 110: 410\u2013414.","DOI":"10.1254\/jphs.09061SC"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nouchi H, Takahara A, Nakamura H, Namekata I, Sugimoto T, Tsuneoka Y, et al. Chronic left atrial volume overload abbreviates the action potential duration of the canine pulmonary vein myocardium via activation of IK channel. <i>Eur J Pharmacol<\/i> 2008; 597: 81\u201385.","DOI":"10.1016\/j.ejphar.2008.09.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Schrope DP, Kelch WJ. Signalment, clinical signs, and prognostic indicators associated with high-grade second- or third-degree atrioventricular block in dogs: 124 cases. <i>J Am Vet Med Assoc<\/i> 2006; 228: 1710\u20131717.","DOI":"10.2460\/javma.228.11.1710"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Pucci G, Battista F, Lazzari L, Dominici M, Boschetti E, Schillaci G. Progression of renal artery stenosis after renal denervation: Impact on 24-hour blood pressure. <i>Circ J<\/i> 2014; 78: 767\u2013768.","DOI":"10.1253\/circj.CJ-13-0997"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Vassallo P, Trohman RG. Prescribing amiodarone: An evidence-based review of clinical indications. <i>JAMA<\/i> 2007; 298: 1312\u20131322.","DOI":"10.1001\/jama.298.11.1312"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation: Canadian Trial of Atrial Fibrillation Investigators. <i>N Engl J Med<\/i> 2000; 342: 913\u2013920.","DOI":"10.1056\/NEJM200003303421302"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Greene HL. The CASCADE Study: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle: CASCADE Investigators. <i>Am J Cardiol<\/i> 1993; 72: 70\u201374.","DOI":"10.1016\/0002-9149(93)90966-G"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. <i>N Engl J Med<\/i> 2002; 346: 884\u2013890.","DOI":"10.1056\/NEJMoa013029"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG. Animal research: Reporting in vivo experiments: The ARRIVE guidelines. <i>Br J Pharmacol<\/i> 2010; 160: 1577\u20131579.","DOI":"10.1111\/j.1476-5381.2010.00872.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL. Guidelines for reporting experiments involving animals: The ARRIVE guidelines. <i>Br J Pharmacol<\/i> 2010; 160: 1573\u20131576.","DOI":"10.1111\/j.1476-5381.2010.00873.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Takahara A, Sugiyama A, Ishida Y, Satoh Y, Wang K, Nakamura Y, et al. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H<sub>1<\/sub> blocker terfenadine-induced torsades de pointes arrhythmias. <i>Br J Pharmacol<\/i> 2006; 147: 634\u2013641.","DOI":"10.1038\/sj.bjp.0706493"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Peschar M, Vernooy K, Vanagt WY, Reneman RS, Vos MA, Prinzen FW. Absence of reverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles. <i>Cardiovasc Res<\/i> 2003; 58: 510\u2013517.","DOI":"10.1016\/S0008-6363(03)00331-6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, Neuberger HR, et al. Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. <i>Hypertension<\/i> 2013; 61: 225\u2013231.","DOI":"10.1161\/HYPERTENSIONAHA.111.00182"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Fridericia LS. The duration of systole in an electrocardiogram in normal humans and in patients with heart disease: 1920. <i>Ann Noninvasive Electrocardiol<\/i> 2003; 8: 343\u2013351.","DOI":"10.1046\/j.1542-474X.2003.08413.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ishizaka T, Takahara A, Iwasaki H, Mitsumori Y, Kise H, Nakamura Y, et al. Comparison of electropharmacological effects of bepridil and sotalol in halothane-anesthetized dogs. <i>Circ J<\/i> 2008; 72: 1003\u20131011.","DOI":"10.1253\/circj.72.1003"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sugiyama A. Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsade de pointes in patients with remodelled hearts. <i>Br J Pharmacol<\/i> 2008; 154: 1528\u20131537.","DOI":"10.1038\/bjp.2008.240"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Sugiyama A, Hashimoto K. Effects of a typical I<sub>Kr<\/sub> channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsade de pointes. <i>Jpn J Pharmacol<\/i> 2002; 88: 414\u2013421.","DOI":"10.1254\/jjp.88.414"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Yoshida H, Sugiyama A, Satoh Y, Ishida Y, Kugiyama K, Hashimoto K. Effects of disopyramide and mexiletine on the terminal repolarization process of the in situ heart assessed using the halothane-anesthetized in vivo canine model. <i>Circ J<\/i> 2002; 66: 857\u2013862.","DOI":"10.1253\/circj.66.857"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Chiba K, Sugiyama A, Satoh Y, Shiina H, Hashimoto K. Proarrhythmic effects of fluoroquinolone antibacterial agents: In vivo effects as physiologic substrate for Torsades. <i>Toxicol Appl Pharmacol<\/i> 2000; 169: 8\u201316.","DOI":"10.1006\/taap.2000.9041"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Yoshida H, Sugiyama A, Satoh Y, Ishida Y, Yoneyama M, Kugiyama K, et al. Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model. <i>Circ J<\/i> 2002; 66: 758\u2013762.","DOI":"10.1253\/circj.66.758"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: Insights into the mechanism of the superior efficacy of amiodarone. <i>Circulation<\/i> 2003; 107: 1440\u20131446.","DOI":"10.1161\/01.CIR.0000055316.35552.74"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Sugiyama A, Satoh Y, Hashimoto K. Acute electropharmacological effects of intravenously administered amiodarone assessed in the in vivo canine model. <i>Jpn J Pharmacol<\/i> 2001; 87: 74\u201382.","DOI":"10.1254\/jjp.87.74"},{"key":"41","unstructured":"41. Kato K, Urano H, Suwa T. The pharmacokinetics of amiodarone in patients following single and repeated administration. <i>The Clinical Report<\/i> 1993; 27: 5261\u20135274."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Tabayashi K, Misbach GA, Miyamoto M, Togo T, Allen M, Thomas R, et al. Hemodynamic effects of oral amiodarone on left ventricular function before and after global ischemia. <i>J Surg Res<\/i> 1992; 52: 271\u2013275.","DOI":"10.1016\/0022-4804(92)90085-E"},{"key":"43","unstructured":"43. Pappano AJ. Properties of vasculature. <i>In<\/i>: Koeppen BM, Stanton BA, editors. Berne &amp; Levy Physiology, 6th update edn. Philadelphia: Mosby Elsevier, 2010; 330\u2013369."},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Volders PGA, Sipido KR, Vos MA, Sp\u00e4tjens RL, Leunissen JD, Carmeliet E, et al. Downregulation of delayed rectifier K<sup>+<\/sup> currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. <i>Circulation<\/i> 1999; 100: 2455\u20132461.","DOI":"10.1161\/01.CIR.100.24.2455"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Takahara A, Wagatsuma H, Aritomi S, Konda T, Akie Y, Nakamura Y, et al. Measurements of cardiac ion channel subunits in the chronic atrioventricular block dog. <i>J Pharmacol Sci<\/i> 2011; 116: 132\u2013135.","DOI":"10.1254\/jphs.11019SC"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. van Opstal JM, Schoenmakers M, Verduyn SC, de Groot SH, Leunissen JD, van Der Hulst FF , et al. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. <i>Circulation<\/i> 2001; 104: 2722\u20132727.","DOI":"10.1161\/hc4701.099579"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/7\/80_CJ-16-0198\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:21:50Z","timestamp":1498317710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/7\/80_CJ-16-0198\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-16-0198","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}